In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cellebrite DI Ltd (NASDAQ: CLBT) was $20.18 for the day, up 6.21% from the previous closing price of $19.00. In other words, the price has increased by $6.21 from its previous closing price. On the day, 1.24 million shares were traded. CLBT stock price reached its highest trading level at $20.25 during the session, while it also had its lowest trading level at $19.09.
Ratios:
Our analysis of CLBT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.01. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 19 ’24 when RONNEN ARMON bought 37,909 shares for $18.50 per share.
MARCUS H JEWELL bought 33,666 shares of CLBT for $588,145 on Nov 19 ’24. On Nov 18 ’24, another insider, MARCUS JEWELL, who serves as the OFFICER of the company, bought 59,588 shares for $17.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 4335532032 and an Enterprise Value of 3606906624. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.90 while its Price-to-Book (P/B) ratio in mrq is 14.08. Its current Enterprise Value per Revenue stands at 9.365 whereas that against EBITDA is 53.701.
Stock Price History:
Over the past 52 weeks, CLBT has reached a high of $21.00, while it has fallen to a 52-week low of $7.91. The 50-Day Moving Average of the stock is 12.60%, while the 200-Day Moving Average is calculated to be 47.34%.
Shares Statistics:
CLBT traded an average of 1.25M shares per day over the past three months and 1666330 shares per day over the past ten days. A total of 203.23M shares are outstanding, with a floating share count of 86.02M. Insiders hold about 58.66% of the company’s shares, while institutions hold 38.72% stake in the company. Shares short for CLBT as of 1730332800 were 1511257 with a Short Ratio of 1.21, compared to 1727654400 on 1347824. Therefore, it implies a Short% of Shares Outstanding of 1511257 and a Short% of Float of 1.35.
